A critical advance in cancer study is emerging with the use of VHH fragments to reactivate dysfunctional p53. This crucial cancer protector protein is frequently lost in various types of cancer, resulting uncontrolled https://wearethelist.com/story24154114/nanobodies-revive-tumor-suppressor-p53-a-promising-approach-for-cancer-management